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ABSTRACT
Objectives: To investigate association of amniotic fluid index (AFI) with perinatal fetal and maternal outcomes in pregnan-
cies complicated by preterm premature rupture of membranes (PPROM)
Material and methods: A total of 70 singleton pregnancies complicated by PPROM at 23–33 weeks’ gestation were enrolled 
in this prospective observational study. Data on maternal clinical and obstetric characteristics [maternal age, gravidity, 
parity, PPROM time, and AFI (cm), latency period, treatments, type of delivery, length of hospital stay (LOS, day)], fetal 
characteristics (gestational age at delivery, birth weight (g), gender) and maternal and fetal complications were recorded 
and compared in AFI < 5 cm (n = 27) and AFI ≥ 5 cm (n = 21) groups.
Results: Overall AFI was ≤ 5 cm in 27 (56.3%) patients and > 5 cm in 21 (43.7%) patients. No significant difference was 
noted in maternal clinical and obstetric characteristics, gestational age at delivery and gender of the newborn as well as 
in maternal and fetal complications rates with respect to AFI groups. AFI was correlated positively with latency period 
(r = 0.399, p = 0.018) and negatively with postpartum LOS (r = –0.314, p = 0.030). 
Conclusions: In conclusion, our findings seems to indicate increased likelihood of shorter latency to delivery and longer 
postpartum LOS with decrease in AFI after PPROM between 23–33 weeks’ gestation, whereas no impact of AFI on mode 
of delivery and fetal or maternal complications. 
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INTRODUCTION
Premature rupture of fetal membranes (PROM), the leak-
age of amniotic fluid prior to labour irrespective of gestation-
al age, occurs in 2–25% of all pregnancies, while PROM before 
37 weeks of gestation occurs in nearly 3% of all pregnancies 
and referred to as preterm PROM (PPROM) [1–4].
Early recognition and appropriate treatment of PPROM 
is crucial for preventing potential adverse perinatal out-
comes related to prematurity (i.e. neonatal morbidity and 
mortality) and for minimizing the risk of fetal and mater-
nal complications [3–6]. However, PPROM continues to be 
a challenging condition in current obstetric practice in terms 
of controversies regarding the optimal timing and route of 
delivery to minimize maternal and perinatal morbidity [3, 5]. 
Amniotic fluid index (AFI), a widely used method for 
evaluation of fetal well–being, is considered a useful pa-
rameter in this regard, given its potential in predicting 
adverse outcomes, aiding to decide on optimal mode of 
delivery in pregnancies complicated by PPROM [5, 7, 8]. 
Accordingly, presence of oligohydramnios (AFI < 5 cm) 
after PPROM has been suggested to be associated with in-
creased likelihood of adverse fetal (i.e. intrauterine growth 
restriction, fetal distress, pulmonary hypoplasia, respiratory 
distress syndrome, neonatal sepsis, necrotizing enterocol-
itis, intraventricular hemorrhage, and bronchopulmonary 
dysplasia) and maternal (i.e. chorioamnionitis) perinatal 
outcomes, contributing to an increase in neonatal sepsis 
and mortality [5, 8–12].
466
Ginekologia Polska 2020, vol. 91, no. 8
www. journals.viamedica.pl/ginekologia_polska
However, the utility of AFI after PPROM in terms of ad-
verse perinatal outcomes has not been extensively studied 
along with considerable controversy among the published 
studies [5, 8, 9, 12–16].
This study was therefore was designed to investigate 
the potential association of AFI with fetal/maternal perinatal 
adverse outcomes in pregnancies complicated by PPROM.
MATERIALS AND METHODS
Study population
A total of 70 singleton pregnancies complicated by 
PPROM at 23–33 weeks’ gestation were enrolled in this 
prospective observational study conducted at a single 
tertiary care center between September 2018 and Sep-
tember 2019. Women with singleton, non–anomalous fe-
tuses with suspected diagnosis of PPROM at 23–33 weeks’ 
gestation and amniotic fluid volume assessment at the 
time of presentation were included in the study. Presence 
of multiple pregnancy, cerclage major congenital anomaly, 
oligohydramnios, polyhydramnios, pregnancy-related hy-
pertensive disorder, cervical dilatation ≥ 6 cm on admis-
sion and delivery within 2 hours of membrane rupture 
were the exclusion criteria of the study. Accordingly, final 
study population subjected to analysis was composed of 
48 pregnant women due to exclusion of 22 women due 
to lack of PPROM diagnosis (n = 13), multiple pregnancy 
(n = 2), cervical dilatation ≥ 6 cm (n = 2), hypertensive dis-
ease (n = 1), cerclage (n = 1), lumbar meningomyelocele 
(n = 1), idiopathic polyhydramnios (n = 1) and discharge at 
her own request (n = 1) (Fig. 1).
Written informed consent was obtained from each 
subject following a detailed explanation of the objec-
tives and protocol of the study which was conducted 
in accordance with the ethical principles stated in the 
“Declaration of Helsinki” and approved by the institutional 
ethics committee.
Assessments
Data on maternal clinical and obstetric characteristics 
[maternal age, gravidity, parity, body mass index prior to 
pregnancy (kg/m2), smoking status, PPROM time, amniotic 
fluid appearance and AFI (cm), latency period (days from 
rupture of amniotic sac to the delivery), treatments (steroid, 
magnesium), type of delivery, length of hospital stay (LOS, 
day)], fetal characteristics (gestational age at delivery, birth 
weight (g), gender) and maternal complications (placental 
abruption, retention, endometritis, bleeding, chorioamnio-
nitis, last CRP before delivery, WBC and body temperature) 
and fetal complications within the first month of post-natal 
life (ICU stay, sepsis, meconium aspiration, respiratory dis-
tress syndrome, grade 3–4 intraventricular hemorrhage, 
umbilical artery pH level and 5th min Apgar score) were 
recorded. Patients were categorized into 2 groups on the 
basis of a 4-quadrant AFI < 5 cm (n = 27) or ≥ 5 cm (n = 21), 
while maternal and fetal characteristics and complications 
were evaluated with respect to AFI groups and correlation 
of AFI with other study parameters was analyzed.
PPROM diagnosis
PPROM diagnosis was based on patient history and 
physical examination findings including presence of typical 
gross amniotic fluid leakage history and/or identification of 
pooling of amniotic fluid in the posterior vaginal vault on 
sterile speculum examination. In women with suspected 
anamnesis but without history of gross leakage or posi-
tive findings on speculum examination, the diagnosis was 
made by positivity of placental alpha microglobulin–1 test 
(Amnisure ROM Test, QIAGEN, USA) in the vaginal fluid. 
The pregnant women were monitored daily by clinical and 
obstetric examination, as well as with bacteriology smears 
and periodic hemogram analysis for screening of infections. 
Calculation of amniotic fluid index (AFI)
AFI was measured ultrasonographically with 4–8 MHz 
transabdominal convex probe General Electric Voluson 
(GE Healthcare, Chicago, IL, United States) device and cal-
culated by four quadrant technique, which is sum of the 
deepest vertical length of pocket of fluid in each quadrant 
without umbilical cord [17].
Treatments
All pregnant women received a single course of beta-
methasone, consisting of two 12–mg injections during the 
first 24 hours after admission to induce fetal lung maturation 
and antibiotic treatment including single dose oral azithro-
mycin (1 g) and i.v. ampicillin (4 × 2 g) within the first 48–h, 
as followed by oral amoxicillin (3 × 500 mg) to complete the 
7–day antibiotherapy [1]. In women with delivery expected 
to occur before 32nd gestational week, magnesium sulphate Figure 1. Study flow chart
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prophylaxis was administered for fetal neuroprotection 
(a loading dose of 6 g infused for 20–30 minutes followed 
by a maintenance infusion of 2 g per hour). 
Emergency C/S was performed in women with placental 
abruption and identification of decelerations indicating fetal 
distress during NST. The decelerations were interpreted in 
accordance with ACOG Bulletin description. 
Fetal and maternal complications
Fetal and maternal complications were recorded up to 
1 month postpartum. Respiratory distress syndrome was 
defined as a requirement for supplemental oxygen for more 
than 48 hours with a reticulogranular appearance on chest 
X–ray. Neonatal sepsis was diagnosed either by positive 
blood culture or by a combination of clinical signs and 
laboratory findings, such as leukopenia, thrombocytopenia, 
and elevated CRP levels. ICU need was considered for at least 
24 hours of ICU stay in the neonatal period. 
Chorioamnionitis was diagnosed based on increased 
body temperature (> 38 °C) accompanied with positivity of 
at least one of the followings: lower abdominal or uterine 
tenderness, malodorous amniotic discharge, persistent fetal 
tachycardia or positive laboratory findings (CRP > 0.5 mg/dL 
or WBC > 20.000) [18]. Postpartum endometritis was di-
agnosed based on increased body temperature (> 38 °C) 
and uterine tenderness and exclusion of other infection 
foci. Postpartum bleeding was considered in bleedings that 
cause 10% decline in hematocrit levels or necessitate blood 
transfusion. 
Statistical analysis
Statistical analysis was made using IBM SPSS Statistics for 
Windows, version 25.0 (IBM Corp., Armonk, NY, USA). Pear-
son Chi-Square test (Exact), Fisher Exact test (Exact), Fisher 
Freeman Halton Test (Monte Carlo) were used to analyze 
categorical data, while numerical data were analyzed with 
independent samples-t test (Bootstrap) and Mann Whitney 
U test (Monte Carlo). Correlation analysis was performed 
with Spearman’s rho test. ROC curve was plotted to deter-
mine the role of AFI in predicting fetal birth weight with 
calculation of area under curve (AUC) and cut-off value via 
ROC analysis. Data were expressed as median (min–max), 
95% confidence interval (CI) and n (%) where appropriate 
p < 0.05 was considered statistically significant.
RESULTS
Overall, mean  ±  SD maternal age was 27.15  ±  5.04 years, 
54.2% of women were multiparous women. Mean PPROM 
time was 29.11 (SD 2.22) weeks, while spontaneous vaginal 
delivery was noted in 81.3% of women. Overall mean  ±  SD 
AFI was 4.41  ±  1.80 cm, while AFI was ≤ 5 cm in 27 (56.3%) 
patients and > 5 cm in 21 (43.7%) patients. Median latency 
period was 8 days (range, 1 to 26 days), while length of 
postpartum LOS was 2.5 days (range, 1 to 7 days) (Tab. 1). 
No significant difference was noted in maternal clinical 
and obstetric characteristics, gestational age at delivery 
and gender of the newborn with respect to AFI groups. La-
tency period and LOS were also similar between AFI < 5 cm 
and ≥ 5cm groups (Tab. 1).
Fetal birth weight was significantly higher in the 
AFI ≥ 5 cm group as compared with AFI < 5 cm group 
(1622.86  ±  273.75 vs 1440.74  ±  336.33, p = 0.042) (Tab. 1).
Maternal and fetal complications
Overall, maternal complications were observed in 41.7% 
of women, including chorioamnionitis (33.3%) and endo-
metritis (25.0%) in most of women (Tab. 2).
Overall, fetal complications were observed in 72.9% of 
neonates, including 5–min Apgar score ≤ 5 (52.1%), ICU stay 
(66.7%), and respiratory distress syndrome (52.1%) in most 
of neonates (Tab. 3).
No significant difference was noted in presence, type 
and number of maternal and fetal complications with re-
spect to AFI groups (Tab. 3).
Correlation of AFI with other study parameters
AFI was correlated positively with latency period 
(r = 0.399, p = 0.018) and negatively with postpartum LOS 
(r = –0.314, p = 0.030). No correlation of AFI was noted with 
maternal age, PPROM time, delivery week or number of 
maternal and fetal complications (Tab. 4). 
DISCUSSION
Our findings revealed positive correlation of AFI with la-
tency period and association of AFI < 5 cm after PPROM with 
higher postpartum LOS in pregnancies complicated by PPROM 
at 23–33 weeks’ gestation, whereas no significant difference 
was noted in fetal and maternal complication rates and mode 
of delivery with respect to AFI groups (< 5 cm vs ≥ 5 cm). 
Increased likelihood of shorter latency to delivery with 
decreasing AFI values after PPROM in the current study sup-
ports the data on association of lower (< 5 cm) AFI values 
with shorter latency to delivery reported from a prospec-
tive analysis of 225 singleton pregnancies complicated by 
PPROM between 24 and 32 weeks’ gestation [12] as well as in 
a retrospective analysis of 389 women with PPROM between 
24 and 34 weeks of gestation [14]. However, in both studies, 
authors also reported association of oligohydramnios after 
PPROM with higher rate of cesarean delivery [12, 14] and 
perinatal adverse outcomes such as early–onset neonatal 
sepsis [12] and chorioamnionitis [12, 14]. In this regard, the 
wide range of latency period length (1–26 days) in the cur-
rent study should also be noted given that this alone may 
also refer to a considerable risk factor of adverse outcome.
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In a retrospective study of 191 pregnancies with PPROM, 
authors reported higher rates of cesarean sections, 5-min 
Apgar score < 7, chorioamnionitis, respiratory distress 
syndrome, composite neonatal morbidity and neonatal 
mortality in the group with an AFI < 5 cm vs those with 
an AFI > 5 cm [19]. Moreover, in a retrospective cohort study 
of 86 pregnant women with PPROM at 24 to 35 weeks’ gesta-
tion, authors reported higher rate of perinatal mortality in 
Table 1. Maternal and fetal characteristics with respect to AFI
Maternal characteristics Total (n = 48) AFI < 5 cm (n = 27) AFI ≥ 5 cm (n = 21) P
Maternal age, Mean ± SD 27.15 ± 5.04 27.15 ± 5.19 27.14 ± 4.97 0.997t
Gravidity, Median (Min/Max) 2 (1/5) 2 (1/5) 2 (1/4) 0.402u
Parity, n (%)        
  Primipar 22 (45.8) 12 (44.4) 10 (47.6) 0.999p
  Multipar 26 (54.2) 15 (55.6) 11 (52.4)  
BMI [kg/m2], n (%)        
  < 18.5 9 (18.8) 4 (14.8) 5 (23.8) 0.664ff
  18.5–24.9 18 (37.5) 9 (33.3) 9 (42.9)  
  25–29.9 12 (25.0) 8 (29.6) 4 (19.0)  
  > 30 9 (18.8) 6 (22.2) 3 (14.3)  
Smoking, n (%)        
  No 44 (91.7) 24 (88.9) 20 (95.2) 0.621f
  Yes 4 (8.3) 3 (11.1) 1 (4.8)  
PPROM time [week], Mean ± SD 29.11 ± 2.22 28.80 ± 2.21 29.51 ± 2.22 0.291t
Amniotic fluid, n (%)        
  Clear 44 (91.7) 24 (88.9) 20 (95.2) 0.999ff
  Bloody 1 (2.1) 1 (3.7) 0 (0.0)  
  Meconium 3 (6.3) 2 (7.4) 1 (4.8)  
Delivery type, n (%)        
  C/S 9 (18.8) 5 (18.5) 4 (19.0) 0.999f
  Vaginal 39 (81.3) 22 (81.5) 17 (81.0)  
AFI, Mean ± SD. 4.41 ± 1.80  3.05 ± 0.97  6.15 ± 0.83 0.001t
Latency period [day], Median (Min/Max) 8 (1/26) 7 (1/19) 9 (1/26) 0.322u
Length of hospital stay [day], Median (Min/Max) 2.5 (1/7) 3 (1/7) 2 (1/7) 0.071u
Steroid, n (%)        
  No 1 (2.1) 1 (3.7) 0 (0.0) –
  Yes 47 (97.9) 26 (96.3) 21 (100.0)  
Magnesium, n (%)        
  No 8 (16.7) 4 (14.8) 4 (19.0) 0.715f
  Yes 40 (83.3) 23 (85.2) 17 (81.0)  
Fetal characteristics
Gestational age at delivery (week), Mean ± SD. 30.31 ± 1.97 29.86 ± 2.02 30.88 ± 1.80 0.078t
< 34 weeks 44 (91.7) 25 (92.6) 19 (90.5) 0.999f
34 weeks 4 (8.3) 2 (7.4) 2 (9.5)  
Birth weight [g], Mean ± SD. 1520.42 ± 320.62 1440.74 ± 336.33 1622.86 ± 273.75 0.042t
Gender, n(%)        
  Girl 26 (54.2) 15 (55.6) 11 (52.4) 0.999p
  Boy 22 (45.8) 12 (44.4) 10 (47.6)  
t — Independent Samples, t —Test(Bootstrap), u — Mann Whitney U test(Monte Carlo), p — Pearson Chi-Square Test(Exact), f — Fisher Exact test(Exact), ff — Fisher 
Freeman Halton Test(Monte Carlo), rc — Roc Curve Analysis (Youden index J-Honley&Mc Nell), AUC — Area under the ROC curve, SD. — Standard deviation, Med 
— Median, Min — Minimum, Max — Maximum
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AFI < 5 cm vs AFI > 5 cm groups, whereas a higher frequency 
of 1-min Apgar scores < 7, neonatal sepsis and early neonatal 
mortality in AFI < 3 cm vs AFI > 3 cm groups [8]. 
Association of AFI scores < 5 cm with increased risk of 
chorioamnionitis and early onset neonatal sepsis [20, 21] 
as well as an association of AFI scores with APGAR scores, 
neonatal respiratory distress syndrome and maternal cho-
rioamnionitis [15] were also reported in other studies. 
Besides, although oligohydramnios has been suggested 
as an important parameter in the evaluation of fetal wellbe-
ing and a warning sign for predicting poor fetal prognosis 
in pregnancies complicated by PPROM [8, 12, 14, 15, 18, 19], 
there is no consensus on the optimal time to induce labor 
to enable a reduction of perinatal risks [7, 8]. 
Indeed, comparable to findings in our cohort, lack of as-
sociation between AFI scores and adverse outcomes in preg-
nancies complicated by PPROM was also reported in other 
studies [5, 15]. In a past study of 161 singleton pregnancies 
complicated by PPROM, authors reported that AFI < 5 cm 
and AFI ≥ 5 cm were similar in terms of gestational age at 
rupture of the membranes, gestational age at the delivery, 
mode of delivery, maternal chorioamnionitis, abruption, 
early onset neonatal sepsis and NICU stay as well as fetal 
birth weight [5]. No significant association of AFI with APGAR 
scores, neonatal RDS and maternal chorioamnionitis was 
also reported in another study [15].
Notably, in a retrospective cohort study in 92 women 
with PPROM, authors reported association of persistent 
Table 2. Maternal complications with respect to AFI
    Total (n = 48) AFI < 5 cm (n = 27) AFI ≥ 5 cm (n = 21) P 
Med (Min/Max) Med (Min/Max) Med (Min/Max)
Number of complications 0 (0/3) 0 (0/3) 0 (0/3) 0.349u
    n (%) n (%) n (%)  
Complications        
  Absent 28 (58.3) 14 (51.9) 14 (66.7) 0.382p
  Present 20 (41.7) 13 (48.1) 7 (33.3)  
Placental abruption        
  Absent 47 (97.9) 26 (96.3) 21 (100.0) –
  Present 1 (2.1) 1 (3.7) 0 (0.0)  
Retention        
  Absent 46 (95.8) 26 (96.3) 20 (95.2) –
  Present 2 (4.2) 1 (3.7) 1 (4.8)  
Endometritis        
  Absent 36 (75.0) 19 (70.4) 17 (81.0) 0.510p
  Present 12 (25.0) 8 (29.6) 4 (19.0)  
Bleeding        
  Absent 45 (93.8) 25 (92.6) 20 (95.2) 0.999f
  Present 3 (6.3) 2 (7.4) 1 (4.8)  
Chorioamnionitis        
  Absent 32 (66.7) 17 (63.0) 15 (71.4) 0.758p
  Present 16 (33.3) 10 (37.0) 6 (28.6)  
CRP        
  normal 36 (75.0) 19 (70.4) 17 (81.0) 0.510p
  elevated 12 (25.0) 8 (29.6) 4 (19.0)  
WBC        
  < 21 38 (79.2) 21 (77.8) 17 (81.0) 0.999f
  > 21 10 (20.8) 6 (22.2) 4 (19.0)  
Body temperature [°C]        
  < 38 32 (66.7) 17 (63.0) 15 (71.4) 0.758p
  > 38 16 (33.3) 10 (37.0) 6 (28.6)  
u — Mann Whitney U test (Monte Carlo), p — Pearson Chi-Square Test (Exact), f — Fisher Exact test (Exact), Med — Median, Min — Minimum, Max — Maximum
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oligohydramnios with lower postnatal survival rate and 
more frequent developmental delay among neonates as 
compared with normal amniotic fluid volume, whereas they 
also indicated that most neonates born alive after PROM and 
persistent oligohydramnios to survive to discharge and to 
be developmentally normal [22]. Similarly, while prolonged 
oligohydramnios following PPROM has traditionally been as-
sociated with poor fetal outcomes including high neonatal 
mortality, an apparent improvement in outcome has also 
been emphasized recently even amongst the highest risk 
infants with documented persistent oligohydramnios [16].
Hence, the controversy regarding the association of 
oligohydramnios with adverse maternal and neonatal out-
come in PPROM in published studies seems to emphasize 
the need for this association to be investigated by further 
larger scale studies with sufficient number of patients with 
low AFI [5, 12, 20, 23].
Although, higher fetal birth weight in the AFI ≥ 5 cm 
group as compared with AFI < 5 cm group in our cohort 
seems consistent with previously reported role of AFI in 
predicting macrosomia in a prospective observational study 






PPROM time –0.120 0.417
Delivery week 0.044 0.765
Birth weight 0.146 0.321
Latency period (day) 0.339 0.018
Post–partum length of hospital stay (day) –0.314 0.030
Total number of maternal complications –0.192 0.191
Total number of fetal complications –0.0002 0.999
Spearman’s rho test, r — Correlation Coefficient
Table 3. Fetal complications with respect to AFI
    Total (n = 48) AFI < 5 cm (n = 27) AFI ≥ 5 cm (n = 21) P 
Number of complications, Median (Min/Max) 2 (0/5) 2 (0/5) 2 (0/5) 0.563u
    n (%) n (%) n (%)  
Complications        
  Absent 13 (27.1) 6 (22.2) 7 (33.3) 0.516p
  Present 35 (72.9) 21 (77.8) 14 (66.7)  
ICU stay        
  Absent 16 (33.3) 8 (29.6) 8 (38.1) 0.758p
  Present 32 (66.7) 19 (70.4) 13 (61.9)  
Sepsis        
  Absent 40 (83.3) 22 (81.5) 18 (85.7) 0.999f
  Present 8 (16.7) 5 (18.5) 3 (14.3)  
Meconium aspiration        
  Absent 46 (95.8) 26 (96.3) 20 (95.2) –
  Present 2 (4.2) 1 (3.7) 1 (4.8)  
Respiratory distress syndrome        
  Absent 23 (47.9) 12 (44.4) 11 (52.4) 0.771p
  Present 25 (52.1) 15 (55.6) 10 (47.6)  
Intraventricular hemorrhage (Grade 3–4)        
  Absent 47 (97.9) 26 (96.3) 21 (100.0) –
  Present 1 (2.1) 1 (3.7) 0 (0.0)  
Umbilical artery pH        
  < 7.1 43 (89.6) 24 (88.9) 19 (90.5) 0.999f
  > 7.1 5 (10.4) 3 (11.1) 2 (9.5)  
5th min Apgar score        
  < 5 25 (52.1) 14 (51.9) 11 (52.4) 0.999p
  > 5 23 (47.9) 13 (48.1) 10 (47.6)  
u — Mann Whitney U test (Monte Carlo), p — Pearson Chi–Square Test (Exact), f — Fisher Exact test (Exact), Med — Median, Min — Minimum, Max — Maximum
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in 600 patients in the first stage of labor before rupture of 
membranes [24], it should be noted that latency period 
and the mean gestational age at the delivery also differed 
between AFI groups emphasizing the birthweight to be 
variable dependent on gestational age and placental factors 
rather than on residual AFI.
In fact, while oligohydramnios has been associated with 
a higher likelihood of caesarean section due to non–reassur-
ing fetal heart rate patterns [5, 12, 20] as well as with longer 
NICU stay [25], our findings revealed similar cesarean sec-
tion delivery rates and length of NICU stay in AFI ≥ 5 cm 
and < 5 cm groups. Nevertheless, caesarean section rate 
(18.8%) in our cohort of women with pregnancies compli-
cated by PPROM at 23–33 weeks’ gestation seems in accord-
ance with the likelihood of an increased risk of maternal 
infection in cesarean sections, particularly in women at risk 
of developing chorioamnionitis [23, 26].
CONCLUSIONS
In conclusion, our findings seem to indicate increased 
likelihood of shorter latency to delivery and longer post-
partum LOS with decrease in AFI after PPROM between 
23–33 weeks’ gestation, whereas no impact of AFI on mode 
of delivery and fetal or maternal complications. Further 
larger scale longitudinal studies in pregnant women with 
PPROM are needed to investigate the utility of AFI as a po-
tential prognostic variable in predicting adverse fetal or 
maternal outcomes.
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